Ignite Creation Date:
2025-12-24 @ 1:40 PM
Ignite Modification Date:
2026-02-25 @ 6:36 PM
Study NCT ID:
NCT01786395
Status:
TERMINATED
Last Update Posted:
2016-01-29
First Post:
2013-01-23
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Phase III Efficacy and Safety Clinical Study of UF-021 for Treatment of Retinitis Pigmentosa
Sponsor:
R-Tech Ueno, Ltd.
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
UF-021-C003
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None